Attard G, Brown LC, Clarke NW, Parmar MKB, et al. Should Patients with High-risk Localised or Locally Advanced Prostate Cancer Receive Abiraterone Acetate in Addition to Androgen Deprivation Therapy? Update on a Planned Analysis of the STAMPEDE Trial. Eur Urol 2021 Jul 14. pii: S0302-2838(21)01864.
PMID: 34274134